Press Releases MAIA Biotechnology, Inc.

Equities

MAIA

US5526411021

Real-time Estimate Cboe BZX Other stock markets 12:38:08 2024-05-20 pm EDT			5-day change	1st Jan Change
3.385 ^USD	+2.27%		+11.48%	+190.60%

Apr. 26	Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	MT
Apr. 22	MAIA Biotechnology, Inc. announced that it expects to receive $0.664994 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024	10:13am	AQ
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING	May. 17	AQ
MAIA Biotechnology to Present at the BIO International Convention 2024	May. 17	BU
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting	May. 16	BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	Apr. 30	BU
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement	Apr. 29	BU
MAIA Biotechnology Announces $1.00 Million Private Placement	Apr. 23	BU
MAIA BIOTECHNOLOGY TO PRESENT AT TWO INVESTOR CONFERENCES IN APRIL 2024	Apr. 08	AQ
MAIA Biotechnology to Present at Two Investor Conferences in April 2024	Apr. 05	BU
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero	Mar. 28	BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	Mar. 26	BU
MAIA Biotechnology Announces $1.33 Million Private Placement	Mar. 26	BU
MAIA BIOTECHNOLOGY ANNOUNCES SHARE PURCHASE BY DIRECTOR STAN SMITH, PHD IN A $2.9 MILLION PRIVATE PLACEMENT	Mar. 25	AQ
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement	Mar. 22	BU
MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board	Mar. 21	BU
MAIA Biotechnology to Participate in the 36th Annual ROTH Conference	Mar. 07	BU
MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting	Mar. 06	BU
MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients	Mar. 06	BU
MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders	Mar. 05	BU
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor	Feb. 27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases MAIA Biotechnology, Inc.

Equities

MAIA

US5526411021

Press Releases

Filters